Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ANNX
ANNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANNX News
Annexon Grants 155,000 Stock Options to New Employees to Advance Immunotherapy
Jan 16 2026
Globenewswire
Biotech Insider Buying Signals Strong, Three Companies Draw Attention
Jan 15 2026
Benzinga
San Francisco Expands Free Childcare Access, Saving Families Thousands Annually
Jan 14 2026
seekingalpha
Annexon Grants 19,000 Stock Options to New Employee at $4.91 Exercise Price
Dec 17 2025
Globenewswire
Annexon Grants 19,000 Stock Options to New Employee at $4.91 Exercise Price
Dec 17 2025
Newsfilter
Annexon Stock Soars Following Director's $5.06 Million Share Acquisition
Nov 20 2025
Yahoo Finance
Insider Buying Update for Thursday, November 20: ANNX, TH
Nov 20 2025
NASDAQ.COM
Wells Fargo Keeps Overweight Rating on Annexon and Increases Price Target to $27
Nov 19 2025
Benzinga
Annexon Unveils Plans for Public Offering of Common Stock and Pre-Funded Warrants
Nov 12 2025
Newsfilter
Annexon, Inc. (ANNX) Shares Insights at Wells Fargo's 20th Annual Healthcare Conference 2025 Transcript
Sep 08 2025
Newsfilter
Annexon Announces Inducement Grant for New Employee in Compliance with Nasdaq Listing Rule 5635(c)(4)
Aug 18 2025
Newsfilter
Annexon Narrows Loss in Fiscal Q2
Aug 14 2025
NASDAQ.COM
Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy
Aug 07 2025
Newsfilter
Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
Jul 24 2025
Newsfilter
Noteworthy Thursday Option Activity: ANNX, SPOT, STNG
Jul 10 2025
NASDAQ.COM
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
Jun 18 2025
Newsfilter
Show More News
